UNITED
      STATES


SECURITIES
      AND EXCHANGE COMMISSION


Washington,
      D.C. 20549





FORM
      10-QSB





x
            QUARTERLY
                REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
              EXCHANGE ACT OF
                1934




For
      the
      Quarter Ended September 30, 2006





or





o
            TRANSITION
                REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
              EXCHANGE ACT OF
                1934







For
      the
      transition period from _______ to ______





Commission
      File Number 000-51140





**CURATECH
      INDUSTRIES, INC.**


**(Formerly
      Jump’n Jax, Inc.)**




(Exact
      name of small business issuer as specified in its charter)


UTAH
              
              87-0649332(State
                  or other jurisdiction of
              
              (I.R.S.
                  Employerincorporation
                  or organization)
              
              Identification
                  No.)







3270
      South 1100 West, South Salt Lake, Utah 84119


(Address
      of principal executive offices)





(801)
      209-0545 (Issuer's telephone number)





Check
      whether the issuer (1) filed all reports required to be filed by Section 13
      or
      15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
      for
      such shorter period that the registrant was required to file such reports),
      and
      (2) has been subject to such filing requirements for the past 9 days.
      Yes x No o





Indicate
      by check mark whether the registrant is a shell company (as defined in Rule
      12b-2 of the Exchange Act). Yes x No o





APPLICABLE
      ONLY TO CORPORATE ISSUERS





State
      the
      number of shares outstanding of each of the issuer's classes of common equity,
      as of the latest practicable date.


Class
              
              Outstanding
                  as of September 30, 2006Common
                  Stock, $.001 par value
              
              3,230,408
  Transitional Small Business Disclosure Format
        (Check one): Yes o No x





TABLE
      OF
      CONTENTS





PART
      I -
      FINANCIAL INFORMATION




Item
                  1.
              Financial
                  Statements.
              3Balance
                  Sheets - September 30, 2006 (unaudited) and December 31,
                  2005.
              4Statements
                  of Operations - three and nine months ended September 30, 2006
                  and 2005
                  (unaudited) .
              5Statements
                  of Cash Flows - three and nine months ended September 30, 2006
                  and 2005
                  (unaudited)
              6Notes
                  to Financial Statements .
              7Item
                  2.
              Management's
                  Discussion and Analysis or Plan of Operations.
              9Item
                  3.
              Controls
                  and Procedures.
              12PART
                  II - OTHER INFORMATIONItem
                  1.
              Legal
                  Proceedings.
              12Item
                  2.
              Unregistered
                  Sales of Equity Securities and Use of Proceeds
              12Item
                  3.
              Defaults
                  Upon Senior Securities
              13Item
                  4.
              Submission
                  of Matters to a Vote of Securities Holders
              13Item
                  5.
              Other
                  Information.
              13Item
                  6.
              Exhibits
                  and Reports on Form 8-K.
              13Signatures
              14


2


**CURATECH
        INDUSTRIES, INC.**
 **(Formerly
        Jump’n Jax, Inc.).**
 
 
 **FINANCIAL
        STATEMENTS**
 
 
 **September
        30, 2006 and December 31, 2005**




PART
      I -
      FINANCIAL INFORMATION





Item
      1.
      Financial Statements





The
      accompanying Balance Sheets of Curatech Industries, Inc. (formerly Jump'n Jax,
      Inc.) at September 30, 2006 and December 31, 2005, related Statements of
      Operations for the three and nine months ended September 30, 2006 and 2005,
      and
      Statements of Cash Flows for the three and nine months ended September 30,
      2006
      and 2005, have been prepared by management in conformity with United States
      generally accepted accounting principles. In the opinion of management, all
      adjustments considered necessary for a fair presentation of the results of
      operations and financial position have been included and all such adjustments
      are of a normal recurring nature. Operating results for the period ended
      September 30, 2006, are not necessarily indicative of the results that can
      be
      expected for the fiscal year ending December 31, 2006.





3


**CURATECH
        INDUSTRIES, INC.**
 (Formerly
        Jump'n Jax, Inc.)
 Balance
        Sheets
  ASSETS
  September
                  30,
              
              December
                  31,2006
              
              2005(Unaudited)CURRENT
                  ASSETSCash
              
              $
              2,067
              
              $
              15,660Total
                  Current Assets
              
              
              2,067
              
              
              15,660FIXED
                  ASSETSEquipment,
                  Net
              
              
              382
              
              
              2,952Total
                  Fixed Assets
              
              
              382
              
              
              2,952TOTAL
                  ASSETS
              
              $
              2,449
              
              $
              18,612LIABILITIES
                  AND STOCKHOLDERS' EQUITY (DEFICIT)Accounts
                  payable
              
              $
              1,280
              
              $
              4,194Total
                  Current Liabilities
              
              
              1,280
              
              
              4,194STOCKHOLDERS'
                  EQUITY (DEFICIT)Common
                  stock; 50,000,000 shares authorized,at$0.001
                  par value, 3,230,408 and 2,430,408 sharesissued
                  and outstanding, respectively
              
              
              3,230
              
              
              2,430Additional
                  paid-in capital
              
              
              109,770
              
              
              79,070Accumulated
                  deficit
              
              
              (111,831
              )
              
              (67,082
              )Total
                  Stockholders' Equity (Deficit)
              
              
              1,169
              
              
              14,418TOTAL
                  LIABILITIES AND STOCKHOLDERS'EQUITY
                  (DEFICIT)
              
              $
              2,449
              
              $
              18,612
 The
                    accompanying notes are an integral part of these financial
                    statements.


4




**CURATECH
                  INDUSTRIES, INC.**(Formerly
                  Jump'n Jax, Inc.)Statements
                  of Operations (Unaudited)
  For
                  the Three
              
              
              For
                  the NineMonths
                  Ended
              
              
              Months
                  EndedSeptember
                  30,
              
              
              September
                  30,2006
              
              
              2005
              
              
              2006
              
              
              2005REVENUES
              
              $
              -
              
              $
              1,500
              
              $
              -
              
              $
              5,115EXPENSESGeneral
                  and Administrative
              
              
              19,943
              
              
              8,510
              
              
              42,179
              
              
              36,406Depreciation
              
              
              857
              
              
              1,051
              
              
              2,570
              
              
              2,766Total
                  Expenses
              
              
              20,800
              
              
              9,561
              
              
              44,749
              
              
              39,172LOSS
                  FROM OPERATIONS
              
              
              (20,800
              )
              
              (8,061
              )
              
              (44,749
              )
              
              (34,057
              )OTHER
                  EXPENSESInterest
                  Expense
              
              
              -
              
              
              -
              
              
              -
              
              
              (2,139
              )Total
                  Other Expenses
              
              
              -
              
              
              -
              
              
              -
              
              
              (2,139
              )NET
                  LOSS
              
              $
              (20,800
              )
              $
              (8,061
              )
              $
              (44,749
              )
              $
              (36,196
              )BASIC
                  LOSS PER SHARE
              
              $
              (0.01
              )
              $
              (0.00
              )
              $
              (0.02
              )
              $
              (0.02
              )WEIGHTED
                    AVERAGE NUMBEROF
                    SHARES OUTSTANDING
              
              
              3,230,408
              
              
              2,428,008
              
              
              2,741,519
              
              
              1,654,500
 The
                    accompanying notes are an integral part of these financial
                    statements.
 5
  **CURATECH
                  INDUSTRIES, INC.**(Formerly
                  Jump'n Jax, Inc.)Statements
                  of Cash Flows (Unaudited)
  For
                  the NineMonths
                  EndedSeptember
                  30,2006
              
              
              2005CASH
                  FLOWS FROM OPERATING ACTIVITIESNet
                  loss
              
              $
              (44,749
              )
              $
              (36,196
              )Adjustments
                  to reconcile net loss tonet
                  cash used by operating activities:Depreciation
              
              
              2,570
              
              
              2,766Common
                  stock issued for services
              
              
              -
              
              
              4,000Services
                  contributed by officers
              
              
              1,500
              
              
              4,000Changes
                  in operating assets and liabilitiesIncrease
                  in accounts payable
              
              
              (2,914
              )
              
              (1,268
              )Increase
                  in accrued interest - related
              
              
              -
              
              
              2,139Net
                  Cash Used by Operating Activities
              
              
              (43,593
              )
              
              (24,559
              )CASH
                  FLOWS FROM INVESTING ACTIVITIES
              
              
              -
              
              
              -CASH
                  FLOWS FROM FINIANCING ACTIVITIESCommon
                  stock issued for cash
              
              
              30,000
              
              
              -Net
                  Cash Provided by Financing Activities
              
              
              30,000
              
              
              -NET
                  DECREASE IN CASH
              
              
              (13,593
              )
              
              (24,559
              )CASH
                  AT BEGINNING OF PERIOD
              
              
              15,660
              
              
              27,839CASH
                  AT END OF PERIOD
              
              $
              2,067
              
              $
              3,280SUPPLIMENTAL
                  DISCLOSURES OFCASH
                  FLOW INFORMATIONCASH
                  PAID FOR:Interest
              
              $
              -
              
              $
              -Income
                  Taxes
              
              $
              -
              
              $
              -NON-CASH
                  FINANCING ACTIVITIESCommon
                  stock issued for services
              
              $
              -
              
              $
              4,000Common
                  stock issued for extinguishment ofrelated
                  party debt
              
              $
              -
              
              $
              64,500Services
                  contributed by director
              
              $
              1,500
              
              $
              4,000
 
 The
                  accompanying notes are an integral part of these financial
                  statements.
 6


**CURATECH
      INDUSTRIES, INC.**


**(Formerly
        Jump’n Jax, Inc.)**
 Footnotes
        to the Financial Statements
 September
        30, 2006 and December 31, 2005




NOTE
        1 -
        BASIS OF FINANCIAL STATEMENT PRESENTATION
 
 The
        accompanying unaudited condensed financial statements have been prepared
        by the
        Company pursuant to the rules and regulations of the Securities and Exchange
        Commission. Certain information and footnote disclosures normally included
        in
        financial statements prepared in accordance with accounting principles generally
        accepted in the United States of America have been condensed or omitted in
        accordance with such rules and regulations. The information furnished in
        the
        interim condensed financial statements includes normal recurring adjustments
        and
        reflects all adjustments, which, in the opinion of management, are necessary
        for
        a fair presentation of such financial statements. Although management believes
        the disclosures and information presented are adequate to make the information
        not misleading, it is suggested that these interim condensed financial
        statements be read in conjunction with the Company's most recent audited
        financial statements and notes thereto included in its December 31, 2005
        Annual
        Report on Form 10-KSB of the Company. Operating results for the three and
        nine
        months ended September 30, 2006 are not necessarily indicative of the results
        that may be expected for the year ending December 31, 2006.
 
 NOTE
        2 -
        GOING CONCERN
 
 The
        Company's financial statements are prepared using accounting principles
        generally accepted in the United States of America applicable to a going
        concern
        which contemplates the realization of assets and liquidation of liabilities
        in
        the normal course of business. The Company has not established revenues
        sufficient to cover its operating costs and allow it to continue as a going
        concern. Management intends to increase operations through expanding its
        operations into other locals, in the interim, management and primary
        shareholders are committed to meeting the Company minimal operating
        expenses.
  NOTE
          3 -
          COMMON STOCK ACTIVITY
 
 In
          May
          2006, the Company issued 200,000 common shares to an unrelated third party
          in
          exchange for services rendered and $30,000 in cash.
 NOTE
          4 -
          AGREEMENT AND PLAN OF MERGER
 
 On
          June
          22, 2006, the Company entered into an Agreement and Plan of Merger to acquire
          MedaCure International, Inc., a Nevada corporation doing business in Utah
          (“MedaCure”). The acquisition will be facilitated by merging the Company’s newly
          created, wholly-owned subsidiary, CuraTech Acquisitions, Inc., with and
          into
          MedaCure, with MedaCure being the surviving entity. As a result of the
          transaction, MedaCure will become the Company’s wholly-owned subsidiary.
 
 In
          connection with the acquisition, on October 4, 2006 the Company changed
          its
          corporate domicile from the State of Utah to Nevada and changed the Company’s
          corporate name to CuraTech Industries, Inc. Accordingly, the Company will
          finalize the acquisition as a Nevada corporation.
  7
  **CURATECH
          INDUSTRIES, INC.**
 **(Formerly
          Jump’n Jax, Inc.)**
 Footnotes
          to the Financial Statements (Continued)
 September
          30, 2006 and December 31, 2005
 NOTE
        4 -
        AGREEMENT AND PLAN OF MERGER (Continued)
 
 Additionally,
        pursuant to the terms of the Agreement, the Company effected, a forward stock
        split of the Company’s issued and outstanding common stock on a 4 shares for 1
        share basis, effective October 4, 2006. The forward stock split increased
        the
        Company’s outstanding shares of common stock from 807,602 shares to 3,230,408
        shares. All references to common stock within these financial statements
        have
        been retroactively restated so as to incorporate the effect of this forward
        stock split.
 
 As
        consideration for the acquisition, current holders of MedaCure common stock
        will
        receive an aggregate of 11,579,167 shares of the Company’s common stock,
        post-split. These shares will represent approximately 78% of the Company’s total
        outstanding shares (post-split) following the transaction. The Company’s current
        stockholders will retain approximately 22% of the outstanding
        shares.
 
 The
        Company anticipates the acquisition of MedaCure to be finalized on or around
        October 16, 2006. Following consummation of the merger transaction, the Company
        will become engaged, through its subsidiary MedaCure International, Inc.,
        in the
        development and bringing to market a certain health supplement that is intended
        to enhance and build-up the body’s natural immune system defenses. MedaCure
        intends to commence commercial marketing of its supplement in the near future
        primarily outside the U.S. Initial marketing in the U.S. will primarily be
        to
        the veterinarian market for use in treating animals. MedaCure also intends
        to
        initiate a collaboration and partnering program that will focus on developing
        business alliances designed to generate sales, applications and marketing
        opportunities.


8


Item
      2.
      Management's Discussion and Analysis or Plan of Operations





The
      following information should be read in conjunction with the financial
      statements and notes thereto appearing elsewhere in this Form
      10-QSB.





Recent
      Events





On
      June
      22, 2006, the Company entered into an agreement and plan of merger to acquire
      MedaCure International, Inc., a Nevada corporation doing business in Utah
      (“MedaCure”). The acquisition is being facilitated by merging our newly created,
      wholly-owned subsidiary, CuraTech Acquisitions, Inc., with and into MedaCure
      with MedaCure being the surviving entity. As a result of the transaction,
      MedaCure will become our wholly-owned subsidiary. In connection with the
      acquisition, we are changing our corporate domicile from the State of Utah
      to
      Nevada and will change our corporate name to CuraTech Industries, Inc.
      Accordingly, we will finalize the acquisition as a Nevada
      corporation.





Under
      the
      terms of the agreement, on October 3, 2006 we effected   we
      will
      effect, prior to the closing of the agreement, a forward stock split of our
      issued and outstanding common stock on a 4 shares for 1 share basis. The forward
      stock split increased our outstanding shares of common stock from 807,602 shares
      to 3,230,408 shares. As consideration for the acquisition, current holders
      of
      MedaCure common stock will receive an aggregate of 11,579,167 shares of our
      common stock, post-split. These shares will represent approximately 78% of
      our
      total outstanding shares (post-split) following the transaction. Current Jump’n
      Jax stockholders will retain approximately 22% of the outstanding
      shares.





On
      June
      16, 2006, our board of directors approved the execution of the agreement with
      MedaCure and the actions anticipated thereby, including the change of domicile,
      name change and forward stock split. The change of domicile, name change and
      stock split were also approved by the holders of a majority of our outstanding
      common stock by written consent.





The
      acquisition was finalized on October 26, 2006. As a result of the acquisition,
      we are relocating our principal offices to those of MedaCure
      located at 6337 Highland Drive, # 1053, Salt lake City, Utah 84121, telephone
      number is (801) 836-9810. We have also changed our trading symbol to “CUTC’
under which our common stock is traded on the Over-the-Counter Bulletin Board.
      We also intend an additional 550,000 shares of our common stock to certain
      individuals in consideration for consulting services rendered. These shares
      will
      be registered under the Securities Act of 1933 by filing a Form S-8 with the
      SEC.





Pursuant
      to the consummation of the merger transaction, we will become engaged, through
      our subsidiary MedaCure International, Inc., in the development and bringing
      to
      market a certain health supplement that is intended to enhance and build-up
      the
      body’s natural immune system defenses. MedaCure intends to commence commercial
      marketing of its supplement in the near future primarily outside the U.S.
      Initial marketing in the U.S. will primarily be to the veterinarian market
      for
      use in treating animals. MedaCure also intends to initiate a collaboration
      and
      partnering program that will focus on developing business alliances designed
      to
      generate sales, applications and marketing opportunities.





Our
      independent auditors have indicated in a footnote to our financial statements
      that we have not yet established an ongoing source of revenues sufficient to
      cover operating costs and to allow us to continue as a going concern. Our
      ability to continue as a going concern is dependent on us securing and
      maintaining adequate capital to fund operating losses until we become
      profitable. If we are unable to close our Agreement and Plan of Merger, or
      secure adequate financing in the near future, allowing us to implement our
      business plan, our ability to continue as a going concern may be compromised,
      and we could be forced to cease operations.




9
 
  Plan of Operation




Our
      primary source of revenues for the past several years has been the operation
      of
      recreational bounce-houses in Southern Utah. Although we have recognized a
      fairly consistent stream of revenues from these operations, we have continued
      to
      operate at a loss over the past several reporting periods. Two of our directors,
      Lane S. Clissold and Steven D. Moulton, have historically provided capital
      to
      supplement our operations and continuing losses and there can be no assurance
      that they will continue to provide these funds in the future. Also, on August 18,
      2005,
      James Todd Wheeler resigned as a director, President and Chief Executive Officer
      of the Company. Mr. Wheeler had been responsible for the day-to-day operations
      of our business and will no longer have an association with the Company.
      Following Mr. Wheeler’s resignation, we were unable to find a suitable
      replacement.





Currently,
      our primary focus is to consummate our Agreement and Plan of Merger with
      Medacure, and to move toward generating revenues from the sale of MedaCure’s
      health supplement products.




Results
      of Operations





Three
      Months Ended September 30, 2006 Compared to Three Months Ended September 30,
      2005





Revenues
      for the three-month period ended September 30, 2006 were zero, representing
      no
      change from the period ended September 30, 2005. All revenues earned by the
      Company during the three months ended September 30, 2005 have been re-classified
      as discontinued operations in the accompanying financial statements.





Total
      operating expenses for the third quarter of 2006 were $20,800, an $11,239
      increase from the comparable period of 2005. This increase was due primarily
      to
      increased legal and accounting fees, as well as increased expenses pertaining
      to
      the Company’s merger negotiations and related due-diligence procedures.





During
      the three month period ended September 30, 2006, the Company recognized a net
      loss of $20,800, compared to a loss of $8,061 during the comparable period
      of
      2005. The increased net loss is due primarily to the elimination of all
      bounce-house revenues during the period, coupled with an increase in operating
      expenses as discussed in the previous paragraph.





Nine
      Months Ended September 30, 2006 Compared to Nine Months Ended September 30,
      2005





Revenues
      for the nine-month period ended September 30, 2006 were zero, representing
      no
      change from the period ended September 30, 2005. All revenues earned by the
      Company during the nine months ended September 30, 2005 have been re-classified
      as discontinued operations in the accompanying financial statements.





Total
      operating expenses for the first nine months of 2006 were $44,749, a $5,577
      increase from the comparable period of 2005. This increase was due primarily
      to
      increased legal and accounting fees pertaining to the Company’s December 2005
      audit and related SEC filings.





During
      the nine month period ended September 30, 2006, the Company recognized a net
      loss of $44,749, compared to a loss of $36,196 during the comparable period
      of
      2005. This increase was due primarily to increased legal and accounting fees,
      as
      well as expenses pertaining to the Company’s merger negotiations and related
      due-diligence procedures.





10




Liquidity
      and Capital Resources





At
      September 30, 2006, we had cash on hand of $2,067 compared to $15,660 as of
      December 31, 2005. The decrease in cash is attributed primarily to our net
      loss
      for the period, partially offset by our issuing 200,000 shares of common stock
      for $30,000 in cash during the period.





We
      estimate our cash requirements for the next 12 months to be approximately
      $25,000. We do not feel that current cash on hand will be sufficient to satisfy
      our cash requirements and, if we are unable to develop and implement a
      profitable business plan, we will be required to seek additional avenues to
      obtain the necessary funds. We have no agreements with anyone to provide future
      capital for the Company. If our directors are unable to provide future funding,
      if the need arises, we may have to look at alternative sources of funding.
      We do
      not have any firm plans as to the source of this alternative funding and there
      is no assurance that such funds will be available or, that even if they are
      available, that they will be available on terms that will be acceptable to
      us.
      In the event we are unable to secure necessary future funding, we may have
      to
      curtail our business or cease operations completely.





At
      September 30, 2006, we had total assets of $2,449 and stockholders' equity
      of
      $1,169, compared to total assets of $18,612 and a total stockholders' equity
      of
      $14,418 at December 31, 2005.





Net
      Operating Loss





We
      have
      accumulated approximately $41,000 of net operating loss carryforwards through
      December 31, 2005, which may be offset against taxable income and income taxes
      in future years. The use of these losses to reduce future income taxes will
      depend on the generation of sufficient taxable income prior to the expiration
      of
      the net operating loss carryforwards. The carry-forwards expire in the year
      2025. In the event of certain changes in control, there will be an annual
      limitation on the amount of net operating loss carryforwards which can be used.
      No tax benefit has been reported in the financial statements for the year ended
      December 31, 2005 because there is a 50% or greater chance that the carryforward
      will not be used. Accordingly, the potential tax benefit of the loss
      carryforward is offset by a valuation allowance of the same amount.





Forward
      Looking and Cautionary Statements





This
      report, including the section entitled "Management's Discussion and Analysis
      or
      Plan of Operations" contains forward-looking statements. These statements relate
      to future events or our future financial performance and involve known and
      unknown risks and uncertainties. These factors may cause the Company's actual
      results, levels of activity, performance or achievements to be materially
      different from those expressed or implied by the forward-looking statements.
      These risks and other factors include those listed under "Risk Factors" and
      elsewhere in this report. In some cases, you can identify forward-looking
      statements by terminology such as "may," "will" "should," "expects," "intends,"
      "plans," anticipates," "believes," "estimates," "predicts," "potential,"
      "continue," or the negative of these terms or other comparable
      terminology.





You
      should be aware that a variety of factors could cause actual results to differ
      materially from the anticipated results or other matters expressed in
      forward-looking statements.





You
      are
      cautioned that any forward-looking statements are not guarantees of future
      performance and are subject to risks and uncertainties. Actual results may
      differ materially from those included within the forward-looking statements
      as a
      result of various factors. Cautionary statements in the risk factors section
      and
      elsewhere in this report identify important risks and uncertainties affecting
      our future, which could cause actual results to differ materially from the
      forward-looking statements made in this report.




11





Item
      3.
      Controls and Procedures.





We
      maintain disclosure controls and procedures that are designed to be effective
      in
      providing reasonable assurance that information required to be disclosed in
      our
      Exchange Act reports is recorded, processed, summarized and reported within
      the
      time periods specified in the SEC rules and forms, and that such information
      is
      accumulated and communicated to our management to allow timely decisions
      regarding required disclosure.





In
      designing and evaluating disclosure controls and procedures, management
      recognizes that any controls and procedures, no matter how well designed and
      operated, can provide only reasonable, not absolute assurance of achieving
      the
      desired objectives. Also, the design of a control system must reflect the fact
      that there are resource constraints and the benefits of controls must be
      considered relative to their costs. Because of the inherent limitations in
      all
      control systems, no evaluation of controls can provide absolute assurance that
      all control issues and instances of fraud, if any, have been detected. These
      inherent limitations include the realities that judgments in decision-making
      can
      be faulty and that breakdowns can occur because of simple error or mistake.
      The
      design of any system of controls is based, in part, upon certain assumptions
      about the likelihood of future events and there can be no assurance that any
      design will succeed in achieving its stated goals under all potential future
      conditions.





As
      of the
      end of the period covered by this report, we carried out an evaluation, under
      the supervision and with the participation of management, including our chief
      executive officer and acting principal financial officer, of the effectiveness
      of the design and operation of our disclosure controls and procedures as defined
      in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based upon that
      evaluation, management concluded that our disclosure controls and procedures
      in
      place do provide reasonable assurance that all necessary disclosures are
      communicated as required.





There
      was
      no change in our internal controls over financial reporting identified in
      connection with the requisite evaluation that occurred during our last fiscal
      quarter that has materially affected, or is reasonably likely to materially
      affect, our internal control over financial reporting.





PART
      II -
      OTHER INFORMATION





Item
      1.
      Legal Proceedings





There
      are
      no material pending legal proceedings to which we are a party or to which any
      of
      our property is subject and, to the best of our knowledge, no such actions
      against us are contemplated or threatened.





Item
      2.
      Unregistered Sales or Equity Securities and Use of Proceeds





This
      item
      is not applicable.




Item
      3.
      Defaults Upon Senior Securities





This
      Item
      is not applicable.




Item
      4.
      Submission of Matters to a Vote of Security Holders





This
      item
      is not applicable.




12


Item
      5.
      Other Information





This
      item
      is not applicable




Item
      6.
      Exhibits and Reports on Form 8-K





(a)
      Exhibits:


Exhibit
                  31.1
              Certification
                  of C.E.O. Pursuant to Section 302 of the Sarbanes-Oxley Act of
                  2002.Exhibit
                  31.2
              Certification
                  of Principal Accounting Officer Pursuant to Section 302 of the
                  Sarbanes-Oxley Act of 2002.Exhibit
                  32.1
              Certification
                  of C.E.O. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant
                  to
                  Section 906 of the Sarbanes-Oxley Act of 2002.Exhibit
                  32.2
              Certification
                  of Principal Accounting Officer Pursuant to 18 U.S.C. Section 13
                  50, as
                  adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
                  2002.




(b)
      Reports on Form 8-K filed during the three months ended September 30,
      2006





None





[SIGNATURES
      FOLLOW ON NEXT PAGE.]




13




SIGNATURES




In
      accordance with the requirements of the Securities Exchange Act of 1934, the
      Registrant caused this report to be signed on its behalf by the undersigned,
      thereunto duly authorized.




CURATECH
              INDUSTRIES, INC.Date:
              November 10, 2006
            By:
            /S/
              LINCOLN DASTRUPLincoln
              Dastrup,President
              and
              Director Date:
                November 10, 2006
              By:
              /S/
                JAROM DASTRUPJarom
                Dastrup,Executive
                  Vice President / Secretary
                Principal
                  Accounting Officer






14